Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Applied Therapeutics Inc (2UV.BE)

Compare
0.2958
+0.0332
+(12.64%)
At close: April 17 at 9:52:10 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
455
455
9,993
--
--
Operating Expense
104,754
104,754
74,528
82,950
105,618
Operating Income
-104,299
-104,299
-64,535
-82,950
-105,618
Net Non Operating Interest Income Expense
3,534
3,534
1,372
685
555
Other Income Expense
-4,859
-4,859
-56,600
-243
-521
Pretax Income
-105,624
-105,624
-119,763
-82,508
-105,584
Net Income Common Stockholders
-105,624
-105,624
-119,763
-82,508
-105,584
Diluted NI Available to Com Stockholders
-105,624
-105,624
-119,763
-82,508
-105,584
Basic EPS
-1.42
-0.76
-1.42
-2.18
-4.12
Diluted EPS
-1.42
-0.76
-1.42
-2.18
-4.12
Basic Average Shares
131,052.7550
139,534.7460
84,244.4940
37,825.4310
25,598.1810
Diluted Average Shares
131,052.7550
139,534.7460
84,244.4940
37,825.4310
25,598.1810
Total Operating Income as Reported
-104,299
-104,299
-64,535
-82,950
-105,618
Total Expenses
104,754
104,754
74,528
82,950
105,618
Net Income from Continuing & Discontinued Operation
-105,624
-105,624
-119,763
-82,508
-105,584
Normalized Income
-100,842
-100,842
-63,190
-82,442
-105,584
Interest Income
3,534
3,534
1,372
685
--
Net Interest Income
3,534
3,534
1,372
685
555
EBIT
-104,299
-104,299
-64,535
-82,950
-105,618
EBITDA
-103,873
-103,873
-64,181
-82,507
-105,203
Reconciled Depreciation
426
426
354
443
415
Net Income from Continuing Operation Net Minority Interest
-105,624
-105,624
-119,763
-82,508
-105,584
Total Unusual Items Excluding Goodwill
-4,782
-4,782
-56,573
-66
--
Total Unusual Items
-4,782
-4,782
-56,573
-66
--
Normalized EBITDA
-99,091
-99,091
-7,608
-82,441
-105,203
12/31/2021 - 2/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NBTX Nanobiotix S.A.
3.2900
-0.30%
 
SLRN Acelyrin, Inc.
2.2000
0.00%
 
KYTX Kyverna Therapeutics, Inc.
1.8600
+1.64%
 
HRTX Heron Therapeutics, Inc.
1.8400
0.00%
 
VYGR Voyager Therapeutics, Inc.
3.1600
+0.96%
 
GOSS Gossamer Bio, Inc.
0.8425
+1.49%
 
IBRX ImmunityBio, Inc.
2.4700
-0.40%
 
TNXP Tonix Pharmaceuticals Holding Corp.
15.71
-0.95%